Page
%P
1 Result(s)
within
Andreas Bergmann
Medicine & Public Health
Emergency Medicine
Pain Medicine
-
Article
Safety and tolerability of non-neutralizing adrenomedullin antibody adrecizumab (HAM8101) in septic shock patients: the AdrenOSS-2 phase 2a biomarker-guided trial
Investigate safety and tolerability of adrecizumab, a humanized monoclonal adrenomedullin antibody, in septic shock patients with high adrenomedullin.
